½ÃÀ庸°í¼
»óÇ°ÄÚµå
1441239
¼¼°èÀÇ Á¤¸Æ³»(IV) ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, Á¦Ç°º°, ÀûÀÀÁõº°, ÀûÀÀÁõ Áúȯº° - »ê¾÷ ¿¹Ãø(2023-2030³â)Global Intravenous Infusion Pump Market Size, Share, Growth Analysis, By By Product(Volumetric Infusion Pumps, Insulin Infusion Pumps), By By Disease Indication(Chemotherapy, Diabetes) - Industry Forecast 2023-2030 |
¼¼°èÀÇ Á¤¸Æ³»(IV) ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 2022³â 53¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2023³â 57¾ï 4,000¸¸ ´Þ·¯¿¡¼ 2031³â¿¡´Â 108¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÏ°í, ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È 8.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
Àü ¼¼°è Á¤¸Æ³»(IV) ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ÀÇ ±ÞÁõ, ÀÇ·á±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ Å« ÆøÀÇ ¼ºÀå¼¼¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù. ÀÌ ÆßÇÁ´Â ¼ö¾×, ¾à¹°, ¿µ¾çºÐÀ» ȯÀÚÀÇ Á¤¸ÆÀ¸·Î Á÷Á¢ ÁÖÀÔÇÏ°í, Á¤È®ÇÏ°í Á¦¾îµÈ ¹æ½ÄÀ¸·Î °ø±ÞÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ÀçÅÃÄ¡·á ¼ºñ½º, ƯÈ÷ Áö¼ÓÀû ¼ö¾× ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÀÓ»ó ȯ°æ¿¡¼ Á¤È®ÇÑ ¾à¹° Åõ¿©ÀÇ Çʿ伺À» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Åõ¾à ¿À·ù¸¦ ÁÙÀÌ°í ȯÀÚ ¾ÈÀü°ú Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ³ë·Âµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ÇâÈÄ ¼ö¾× ÆßÇÁ ½ÃÀåÀÇ ¹ßÀüÀº ȯÀÚÀÇ ¾ÈÀü°ú Ä¡·á È¿°ú¸¦ ÃÖ¿ì¼±À¸·Î ÇÏ´Â Á÷°üÀûÀÌ°í »óÈ£ ¿¬°á¼ºÀÌ ³ôÀº ±â±â ½ÃÀå °³Ã´°ú ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎÀÇ ÁøÈÇÏ´Â ¿ä±¸ »çÇ×À» ÃæÁ·½ÃÅ°±â À§ÇÑ µ¥ÀÌÅÍ ±â¹Ý ±â¼ú°ú ȯÀÚ Á᫐ ¼³°èÀÇ Áö¼ÓÀûÀÎ ÅëÇÕ¿¡ ´Þ·Á ÀÖ½À´Ï´Ù.
Global Intravenous Infusion Pump Market size was valued at USD 5.3 billion in 2022 and is poised to grow from USD 5.74 billion in 2023 to USD 10.86 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2024-2031).
The global market for intravenous (IV) infusion pumps has witnessed substantial growth, attributed to the increasing prevalence of chronic illnesses, a burgeoning elderly population, and advancements in medical technology. These pumps play a pivotal role in delivering fluids, medications, and nutrients directly into patients' veins with precision and control. Key drivers of this market expansion include the growing demand for home healthcare services, especially for continuous infusion therapies, and the imperative for precise drug administration in clinical environments. Additionally, efforts to mitigate medication errors, enhance patient safety, and improve treatment outcomes contribute to market momentum. The future trajectory of the IV infusion pump market hinges on the development of intuitive, interconnected devices prioritizing patient safety and treatment efficacy, as well as the ongoing integration of data-driven technologies and patient-centered designs to meet the evolving requirements of healthcare providers and patients alike.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Intravenous Infusion Pump Market Segmental Analysis
The Global Intravenous Infusion Pump Market is segmented on the basis of Product, Disease Indication, and region. By Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps, Others. By Disease Indication, the market is segmented into Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Intravenous Infusion Pump Market
The rising occurrence of chronic conditions like cancer, diabetes, and cardiovascular ailments, combined with a worldwide aging demographic, fuels the necessity for intravenous (IV) infusion pumps. These tools play a vital role in precisely delivering medications, fluids, and nutrients to patients undergoing extended treatments, thereby enhancing disease control and fostering better patient results.
Restraints in the Global Intravenous Infusion Pump Market
Advanced intravenous infusion pumps, though highly effective, may pose significant financial challenges due to their expensive acquisition and maintenance costs, including calibration, upkeep, and training expenses. Such financial burdens can significantly strain healthcare budgets, posing a formidable barrier for healthcare facilities, especially in resource-limited settings or areas with constrained financial resources dedicated to healthcare.
Market Trends of the Global Intravenous Infusion Pump Market
The surge in Smart and Connected Infusion Pumps, which amalgamate technology and connectivity, marks a notable advancement in intravenous infusion systems. These intelligent pumps provide functionalities like dose calculation aid, seamless wireless integration with electronic health records (EHR) systems, and live monitoring of infusion metrics. This trend not only elevates patient safety but also enhances healthcare provider workflow efficiency, enabling remote monitoring and adjustments. The momentum towards digital healthcare solutions has spurred the uptake of smart infusion pumps, promising to mitigate medication errors and optimize the administration process.